Weekend high-Dosage prednisone: A new option for treatment of duchenne muscular dystrophy

Neurology

Volumn 77, Issue 5, 2011, Pages 416-417

  Moxley III, Richard T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFLAZACORT; PREDNISONE;

BODY MASS; BODY WEIGHT; CARDIOPULMONARY FUNCTION; CONTRACTURE; CORTICOSTEROID THERAPY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG TOLERABILITY; DUCHENNE MUSCULAR DYSTROPHY; EDITORIAL; FOLLOW UP; FORCED VITAL CAPACITY; HEART FUNCTION; HUMAN; LUNG FUNCTION; MOBILIZATION; MUSCLE FUNCTION; MUSCLE STRENGTH; OPEN STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SCOLIOSIS; SIDE EFFECT; SURVIVAL; WEIGHT GAIN;

EID: 80051481025     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318227b272     Document Type: Editorial

References (8)

1. Moxley RT III, Ashwal S, Pandya S, et al. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2005;64:13-20.
2. Balaban B, Matthews DJ, Clayton GH, Carry T. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. Am J Phys Med Rehabil 2005;84:843-850. (Pubitemid 41546724)
3. Biggar WD, Harris VA, Eliasoph L, Alman B. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 2006;16:249-255.
4. King W M, Ruttencutter R, NagarajaHN, et al. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology 2007;68:1607-1613. (Pubitemid 46717986)
5. Houde S, Filiatrault M, Fournier A, et al. Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 2008;38:200-206. (Pubitemid 351221232)
6. Moxley RT III, Pandya S, Ciafaloni E, Fox DJ, Campbell K. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol 2010;25:1116-1129.
7. Escolar DM, Hache LP, Clemens PA, et al. Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy. Neurology 2011;77:444-452.
8. Connolly AM, Schierbecker J, Renna R, Florence J. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy. Neuromuscul Disord 2002;12:917-925. (Pubitemid 35414370)